The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor

Journal of Investigative Dermatology

Volumn 117, Issue 5, 2001, Pages 1075-1082

  Burbach, Guido J ^a   Kim, Kyu H ^b   Zivony, Adam S ^a   Kim, Amy ^a   Aranda, Jennifer ^a   Wright, Stacey ^a   Naik, Shubhada M ^a   Caughman, S Wright ^a   Ansel, John C ^a,c   Armstrong, Cheryl A ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Seoul National University   (South Korea)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Keratinocyte; Nerve growth factor; Neuro peptides; Neuroinfammation

Indexed keywords

CAPSAICIN; KERATINOCYTE GROWTH FACTOR; NEUROKININ A; RECEPTOR BLOCKING AGENT; SUBSTANCE P;

ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; KERATINOCYTE; MOUSE; NERVE REGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE; TISSUE REPAIR; WOUND HEALING;

EID: 0035725126     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01498.x     Document Type: Article

References (65)

1. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system
2. Depletion of nerve growth factor in leprosy
3. The role of endogenous nerve growth factor in human diabetic neuropathy
4. Nerve growth factor levels in cultured human skin cells. Effect of gestation and viral transformation
5. Skin-nervous system interactions
6. Interactions of the skin and nervous system
7. Puri(r)cation of a new neurotrophic factor from mammalian brain
8. Neurotrophin- 5. A novel neurotrophic factor that activates trk and trkB
9. Effect of topical application of nerve-growth factor on pressure ulcers
10. cDNA sequence of human beta-NGF
11. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum free media
12. Neuropeptide modulation of keratinocyte cytokine production
13. Induction of NGF by isoproterenol, 4-methylcatechol and serum occurs by three distinct mechanisms
14. A nerve growth stimulating factor isolated from sarcoma 37 and 180
15. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes
16. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo
17. Delayed effect of denervation on wound contraction in rat skin
18. Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats. Effects of insulin treatment
19. Biological importance of the retrograde axonal transport of nerve growth factor in sensory neurons
20. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary
21. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells
22. Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection
23. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: Role of macrophages
24. Innervation and vasculature of human sweat glands: An immunohistochemistry-laser scanning confocal fluorescence microscopy study
25. Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: Correlation with density of sympathetic innervation
26. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation
27. Peptides and cutaneous polymodal nociceptor neurones
28. Mast cells synthesize, store, and release nerve growth factor
29. The nerve growth factor: Thirty-five years later
30. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: Relationship to tests of neurological function
31. Nerve growth factor. Acceleration of the rate of wound healing in mice
32. Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts
33. Transforming growth factor-beta 1 stimulates expression of nerve growth factor in the rat CNS
34. Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis
35. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF
36. Role of nerve growth factor in cutaneous wound healing: Accelerating effects in normal and healing-impaired diabetic mice
37. Cell-type-specific regulation of nerve growth factor (NGF) synthesis in non-neuronal cells: Comparison of Schwann cells with other cell types
38. Highly potent and selective heptapeptide antagonists of the neurokinin NK- 2 receptor
39. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification
40. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR
41. Hayashi. Human fibroblast cells synthesize and secrete nerve growth factor in culture
42. Requirement of nerve growth factor for development of substance P-containing sensory neurones
43. Nerve growth factor: Its significance in cutaneous biology
44. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes
45. Neurokinin receptors. Comparison of data from classical pharmacology, binding, and molecular biology
46. The epidermal nerve fibre network. Characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations
47. Neural innervation and healing
48. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction
49. Use of an experimental autoimmune model to define nerve growth factor dependency of peripheral and central substance P-containing neurons in the rat
50. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia
51. Nerve growth factor production by lymphocytes
52. Effect of experimental treatment on housekeeping gene expression: Validation by real-time, quantitative RT-PCR
53. Neuropeptides in the skin. Interactions between the neuroendocrine and the skin immune systems
54. Immunohistochemical detection of human skin nerve fibers
55. Bioassay detection of mouse nerve growth factor (mNGF) in the brain of adult mice
56. Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin-2 receptor (NK-2R)
57. Quantification of mRNA in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR
58. Deficient axonal transport of substance P in streptozotocin-induced diabetic rats. Effects of sorbinil and insulin
59. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: Further support for a functional relationship between Langerhans cells and epidermal nerves
60. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212)
61. Human beta-nerve growth factor gene sequence highly homologous to that of mouse
62. Isolated hepatic granulomas from mice infected with Schistosoma mansoni contain nerve growth factor
63. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition
64. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity
65. Pharmacological profile of a tachykinin antagonist, spantide, as examined on rat spinal motoneurons